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ABSTRACT
Hossain, M. Jayed. M.S.M.E., Purdue University, August 2018. Factors Influenc- 
ing Cartilage Wear in an Accelerated In Vitro Test: Collagen Fiber Orientation, 
Anatomic Location, Cartilage Composition, and Photo-Chemical Crosslinking. Maj-  
or Professor: Diane Wagner.
  Articular cartilage (AC) is a strong but flexible connective tissue that covers and 
protects the end of the long bones. Although cartilage has excellent friction and wear 
properties that allow smooth joint function during daily activities, these properties
are not fully understood. Many material properties of cartilage are anisotropic and 
vary with anatomic location and the composition of the tissue, but whether this is 
also true for cartilage friction and wear has not been previously determined. Further- 
more, cartilage disease and injury are major health concerns that affect millions of
people, but there are few available treatments to prevent the progression of cartilage 
degeneration. Collagen crosslinking may be a potential treatment to reduce cartilage 
wear and slow or prevent the progression of cartilage disease. The objectives of this 
thesis were to investigate the relationships between the friction/wear characteristics of
cartilage and the orientation of the preferred fiber direction, the anatomic location of 
the tissue, the composition of the tissue, and exogenous photochemical crosslinking.
  In the superficial zone, AC has preferential fiber direction which leads to anisotropic 
material behavior. Therefore, we hypothesized that AC will show anisotropic behav-
ior between longitudinal and transverse direction in an accelerated, in vitro wear test 
on bovine cartilage in terms of friction and wear. This hypothesis was proven by the 
quantification of glycosaminoglycans released from the tissue during the wear test, 
which showed that more glycosaminoglycans were released when the wear direction
was transverse to the direction of the fibers. However, the hydroxyproline released
xv
from the tissue during the wear test was not significantly different between the two
directions, nor was the coefficient of friction.
The material properties of AC can also vary with anatomic location, perhaps due
to differences in how the tissue is loaded in vivo. We hypothesized that cartilage
from a higher load bearing site will give better wear resistance than cartilage from
lower load bearing regions. However, no differences in friction or wear were observed
between the different anatomic locations on the bovine femoral condyles. The con-
centration of collagen, glycosaminoglycans, cells and water in the tissue was also
quantified, but no significant differences in tissue composition were found among the
locations that were tested.
Although wear did not vary with anatomic location, variation in the wear mea-
surements were relatively high. One potential source of variation is the composition
of the cartilage. To determine whether cartilage composition influences friction and
wear, a correlation analysis was conducted. An accelerated, in vitro wear test was
conducted on cartilage from bovine femoral condyles, and the tissue adjacent to the
wear test specimens was analyzed for collagen, glycosaminoglycan, cell, and water
content. Because wear occurs on the cartilage surface, the superficial zone of the
cartilage might play an important role in wear test. Therefore, composition of the
adjacent cartilage was determined in both the superficial zone and the full thickness
of the tissue. A significant negative correlation was found between wear and collagen
content in the full thickness of the tissue, and between the initial coefficient of friction
and the collagen content in the superficial zone. This correlation suggests that vari-
ation in the collagen content in the full thickness of the cartilage partially explains
differences in amount of wear between specimens.
The wear resistance of cartilage can be improved with exogenous crosslinking
agents, but the use of photochemical crosslinking to improve wear resistance is not well
understood. Two photochemical crosslinking protocols were analyzed to improve the
wear resistance of the cartilage by using chloro-aluminum phthalocyanine tetrasulfonic
acid (CASPc) and 670nm laser light. The cartilage treated with the two crosslinking
xvi
protocols had lower wear than the non-treated group without changing the friction
properties of the cartilage.
11. BACKGROUND
1.1 Cartilage Structure and Function
Cartilage is a strong but flexible connective tissue that covers and protects the
ends of the long bones and is a structural component of ribs, nose, ears and many other
body components. Depending on its structure and function, cartilage is classified as
articular cartilage, fibrocartilage or elastic cartilage. Elastic cartilage is responsible
for the shape of ear, trachea, etc. Articular cartilage (AC) is found in load bearing
surfaces at the end of the bones. It is a resilient load-bearing material in diarthrodial
joints, and provides joints with the excellent friction, lubrication and wear resistance
characteristics during sliding motion. It also absorbs shock load and spreads the
applied load to the supporting bone. Fibrocartilage is a strong and tough tissue
found predominantly in intervertebral disks, menisci, and at the insertion site of
ligaments and tendons. This is a type of fibrous tissue containing cartilage ground
substance and chondrocytes.
Load bearing joints like the hip or knee consist of articular cartilage (AC), synovial
fluid, and synovial membrane and are enclosed by a joint capsule [1]. Synovial fluid
acts as a lubricant for the AC. The thickness of the AC of femoral condyles of the
knee is on average 2.21mm in humans [1]. Normal AC is white, with a smooth surface,
and no blood supply.
In normal AC, water content is 65-80% of its total wet weight [2]. The remaining
weights are divided in two major classes of extracellular matrix (ECM) with chon-
drocytes distributed through the tissue. Chondrocytes generate the ECM, and these
cells are responsible for the maintenance of the matrix. These cells are metabolically
active and respond to variety of stimuli [3]. The major components of ECM are pro-
teoglycans, collagens and water with other lower amount proteins and glycoproteins.
2The AC matrix contains different types of collagen like type II, VI, IX, and XI, but
type II collagen is 90-95% of all collagens [2]. The main function of collagen is to
provide tensile properties of the tissue and to immobilize the proteoglycan within the
ECM.
The AC is divided into four zones: superficial zone (12-20% of total thickness),
middle zone (40-60%), deep zone (30%) and calcified zone (Fig:1.1) [2]. In the superfi-
cial zone the collagen fibers are oriented parallel to the joint surface, in the middle zone
the collagens are randomly oriented, in the deep zone the collagen fibers are perpen-
dicular to the joint surfaces, and the calcified zone is the boundary between cartilage
and subchondral bone [4]. The superficial zone is responsible for withstanding shear
force during sliding motion, the middle zone is responsible for carrying compressive
loads and the deep zone also provides resistance to compressive forces [5]. The su-
perficial zone is rich in collagen and relatively poor in proteoglycans. In the middle
zone, concentration of proteoglycan increases and collagen content decreases [2, 4].
Collagen fibers are thin (10-100nm) and crosslink to other fibers to create a con-
tinuous a collagen network [2]. Collagen fibril structure is a triple helix composed
of three polypeptide chains. The amino acid composition of these chains includes
large quantities of glycine and proline. Due to the proline content, the individual
chains exhibit characteristics of left handed helical configuration and the assembled
triple helix winds around a common axis in a right handed configuration; this unique
structure resist tensile forces. Amino acids hydroxyproline (HYP), hydroxylysine,
and glycosylated hydroxyproline are also present [2]. Hydroxyproline is responsi-
ble for the stability of the collagen helix at body temperature due to the formation
of intramolecular hydrogen bonds along the length of the molecule. Hydroxylysine
is involved in the covalent crosslink formation which mainly stabilize collagen fibril
assemble.
Proteoglycans are complex macromolecules and consist of a protein core linked
with extended polysaccharides. Proteoglycans in cartilage are 80-90% large, aggre-
gating type known as aggrecan. The aggrecan monomer consist of a large extended
3Fig. 1.1. Diagram of collagen fiber architecture in a sagittal cross
section. This figure has been reproduced from ref [2].
4protein core with around 100 chondroitin sulfate and 50 keratan sulfate glycosamino-
glycans (GAGs) chains. Many aggrecan monomers (up to 200) can bind to a single
chain of hyaluronate to create a proteoglycan aggregate. Because of their size, ag-
grecan molecules are thought to become immobilized within the collagenous network
of cartilage. They are not homogenously distributed in cartilage. The superficial
zone is rich in collagen and poor in proteoglycans; the concentration of proteoglycans
increases in the middle zone. The distribution and concentration of GAGs in carti-
lage will change with age and diseases. GAGs have negative charges which attracts
water and positive ions through physiochemical mechanisms such as Donnan osmotic
pressure caused by the free positive ion like Ca+2 and Na+ and through electrostatic
repulsive force developed between the fixed negative charges. In the AC, the amount
of hydration is determined by the balance of total swelling pressure exerted by the
GAGs and the constraining forces developed within the collagen network surrounding
the trapped proteoglycans. When water interacts with these macromolecules, a cohe-
sive and strong gel is formed that allows the tissue to hold water. Water flows through
the tissue and across the articular surfaces to promote nutrient transportation and
lubrication of the joint.
1.2 Biphasic Nature of Cartilage
Articular cartilage in diarthrodial joints is subjected to high static, cyclic and
repetitive loads. Therefore, the structure of the molecules like collagen, proteoglycan
etc. are organized into a strong, fatigue-resistant and tough tissue capable of absorb-
ing these loads. The solid matrix is permeable, porous and very soft. Water passes
through the porous-permeable solid matrix when a pressure gradient is applied. The
behavior of cartilage is naturally biphasic as it is composed of both water and solid
matrix [2,6]. An applied load to the cartilage surface is initially carried primarily by
interstitial fluid pressure, the interstitial fluid begins to flow and exudation occurs
due to the load. After the external load is removed, proteoglycans attract water and
5pull the fluid back into the cartilage, like a sponge soaking up water, in preparation
for the next load.
Articular cartilage responds like a viscoelastic material during loading and defor-
mation [2, 6]. During a constant compressive load, deformation increases with time,
creeping until an equilibrium strain is reached. Similarly, when a constant strain is
applied, stress relaxation occurs [2, 6]. Compressive loads generate interstitial fluid
pressure; as creep continues under a constant load, the fluid phase load support grad-
ually transfers to the solid phase. In normal cartilage, the equilibrium process takes
2.78 to 5.56 hrs [2]. In equilibrium, maximum load is supported by the collagen-
proteoglycan solid matrix. Because of this long equilibrium time and always-dynamic
loading condition, cartilage rarely comes to equilibrium under physiologic conditions.
The solid matrix of cartilage is very soft with very low permeability (10−15 to 10−16
m4/Ns) which is responsible for this unique behavior [2].
1.3 Cartilage Diseases and Treatments
Osteoarthritis(OA) is the most common orthopedic disease; approximately 27 mil-
lion adults in the United States have clinical OA (up from the estimate of 21 million
for 1995) [7]. It is a slowly progressive disorder of unknown etiology. Although OA
is commonly associated with aging, younger people who sustain joint injury are also
susceptible to this disease. Mammalian AC has the ability to respond to functional
demands, can withstand single or multiple, moderate or high impact loads. How-
ever, repetitive or excessing load can cause damage to the cartilage. Although injury
normally causes a localized or focal cartilage defect, this can lead to OA if left un-
treated. This progression to a debilitating joint disease from an overload injury is
called post-traumatic osteoarthritis (PTOA) and is responsible for 12% of all OA
cases [8,9]. In the progression of PTOA, cartilage becomes weakened due to both the
mechanical and biological responses and makes the tissue more susceptible to wear
and degeneration. When the impact overload or excessive repetitive load occurs, the
6chondrocytes die, the matrix is damaged, the collagen fiber network breaks down,
fissures are created at the articular surface, and the underlying bone is injured [10].
As a result, changes in the composition and micro structure of cartilage could initiate
the progression towards OA.
Biochemical degradation is also responsible for cartilage diseases. It is promoted
by different cytokines, like as IL1 (interleukin-1) and TNF (tumor necrosis factor-).
The synthesis of the structural macromolecules is hindered by the cytokines acti-
vation through the emission of proteinases from the chondrocytes [11]. Cartilage
regeneration and biochemical degeneration occurs simultaneously. With aging, the
regeneration rate becomes lower than the degeneration rate and OA develops.
The most common treatment for severe OA, including PTOA, is to replace the
joint with an artificial implant; around $9 billion per year have been spent for hip or
knee replacement in the US alone [12]. Different techniques have been developed to
repair the cartilage tissue instead of replacing the entire joint, such as osteochondral
allograft and autograft transplantation, microfracture, ACI (Autologous Chondro-
cytes implantation), MACI (Matrix-induced Autologous Chondrocyte Implantation),
MMP (matrix metalloproteinase) inhibitors and tissue engineering [13]. Most of these
treatments have advantages and limitations [14]. Autograft involves the transfer of
AC from a healthy region to the defect to rapidly restore load bearing capacity and
cartilage structure. The limitation of this procedure is the lack of healthy cartilage
in donor sites and donor site morbidity. Allografts are similar to autografts, but
the donor tissue is from a different individual than the host. The limitation of this
process is insufficient integration between donor and host cartilage, and more signifi-
cantly the immune response [13]. ACI is the injection of chondrocytes in suspension
under a periosteal flap; this is encouraging for smaller defects and low load bearing
sites. This treatment uses adult human chondrocytes, perhaps from OA cartilage,
which possess a restricted capacity to form healthy tissue. MACI is similar to ACI
but uses a scaffold which is cut to the defect shape and seeded with autologous chon-
drocytes and secured in the defect using a fibrin glue [15]. Chronic inflammation
7occurs in OA, which is associated with a feedback cycle that augments degenerative
pathways that activate MMPs. Using MMP inhibitors after the injury can reduce
the degenerative process [13]. In different tissue engineering strategies, cells are used
in combination with scaffolds to generate a cartilage plug in vitro for implantation in
the joint [16]. Finally, biological based experimental treatments such as interleukin
antagonist may be isolated from each patients blood and delivered locally into the
joint to treat OA [17]. One limitation of these biological treatments is that they are
not effective in repairing mechanical damage or preventing the damage from progress-
ing to OA. Therefore, researchers are investigating exogenous crosslinking treatments
which increase the mechanical properties of the cartilage tissue.
1.4 Cartilage Friction and Wear
Synovial fluid inside the synovial membrane performs three main functions. First,
it carries nutrients to the cartilage, second, it removes the waste products and finally,
it provides lubrication in the AC joints [18]. During walking or running, high loads
occur for a shorter period, while low loads occur for a longer period [19]. These
performance characteristics require an efficient lubrication process. The properties of
AC and lubrication by synovial fluid serve together to attain this lubrication process.
The dynamic friction coefficient was found to be 0.002 to 0.02 in diarthrodial joints
of humans with lubricants [18,19]. Many in vitro frictional analyses have been done;
some of them use cartilage on cartilage, cartilage on glass, or cartilage on steel [20].
As a lubricant, some studies have used synovial fluid or phosphate buffered saline
(PBS) [21, 22]. When a load is applied, at first it is carried by the fluid inside the
cartilage via hydrostatic pressure. In this case, fluid pressure provides significant
component of load support and minimizes stress acting on the solid matrix. With
time, the amount of fluid will reduce in the AC until an equilibrium condition is
reached. At that time, the load carried by the solid matrix will be at its maximum.
Fluid is not responsible for frictional forces. So, during loading the fluid moves out
8from the cartilage, load is transferred to solid matrix, and consequently the friction
increases. In the equilibrium condition, frictional force will be maximum. As a result
wear takes place.
Wear is the material removal from the contact surfaces. Once wear starts, the
collagen fibers may break and proteoglycans may be released from the cartilage tissue.
The amount of wear has been measured by different biochemical methods, physical
measurements and microscopy [22]. MRI or magnetic resonance imaging has been
used to measure the wear of cartilage [23]. Biochemical markers can also measure
the presence of cartilage degradation products in the joint fluid [24–26]. The amount
of collagen that is worn from the tissue can be determined through a hydroxyproline
(HYP) assay [27], because HYP is an amino acid constituent that is found almost
exclusively in collagen; the amount of HYP wear is proportional to the amount of
collagen wear. Glycosaminoglycans (GAGs) are a constituent of proteoglycans. So,
by quantifying the GAGs that are released in the solution bath during the wear test,
wear also can be measured as the amount of this component of the extracellular
matrix that has been removed from the tissue.
1.5 Cartilage Crosslinks
Cartilage crosslinks are covalent bonds between individual collagen molecules [28].
The integrity and tensile properties of AC are attributed to this collagen network and
the strength of the bond. Two types of crosslinks are native and exogenous crosslinks.
Native crosslinking is the process where crosslink occurs without external treatment;
this is a biochemical process. Pyridinoline (PYD) is an example of a native crosslink
that increases in concentration from fetal to adult age [29].
Exogenous crosslinking can be used to increase the strength of collagen net-
work [30–32]. One type of crosslinking was formed from advance glycation end prod-
ucts (AGEs) and resulted in increased tissue stiffness and decreased cartilage degener-
ation by matrix metalloproteinases (MMP) [27,33]. Glutaraldehyde and formaldehyde
9fixation via crosslinking has also been shown to increase the wear resistance of car-
tilage in vitro [30–32]. Gluteraldehyde fixation of healthy bovine cartilage increased
the stiffness by 28% and decreased the wear by 20% [30]. From another study, it was
found that the equilibrium compressive modulus can be increased approximately 50%
to 120% in native cartilage by using genipin [34].
Chemical crosslinking cannot be applied to a localized position. For this crosslink-
ing, full AC specimens such as knee joints have been submerged in the crosslink-
ing solution; it is difficult to soak a particular area only. For that reason, another
crosslinking method is being tested, which is known as photo-initiated crosslinking.
In this process, both a photo-reactive chemical and light are used. Because the ap-
plication of light can be delivered to a particular location, just the impacted site can
be crosslinked. Photo-initiated crosslinking can occur through two processes or reac-
tions. In a Type-I process, electron/hydrogen transfer directly from the substrate to
oxidate the protein side chains. In aType-II process, singlet oxygen is formed by the
photo oxidation of the substrate, and protein oxidation is a secondary event [35].
Cartilage crosslinking can be used to adhere implanted cartilage to the surrounding
host tissue. This integration is required for nutrient transport, molecular deposition
to enhance initial integration, and to transmit stress between the tissues [35].
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2. THE EFFECT OF COLLAGEN FIBER ORIENTATION
IN ACCELERATED WEAR TEST OF ARTICULAR
CARTILAGE
2.1 Introduction
Cartilage is an anisotropic material with a continuous fiber network and ma-
trix [36]. Collagen fibers are similar to the fiber in a composite material, and the
proteoglycans and other materials are similar to the matrix . In the superficial zone,
the fiber is parallel to the surfaces, and in the middle zone fibers are in random di-
rections and in the deep zone fibers are perpendicular to the surface (Fig:1.1). In the
superficial zone, fibers have a preferential direction [4], which can be found through
a split line analysis. In a split line analysis, the AC surface is pierced by a pin and
using India ink, a split line indicating the direction of the fibers at that location is
revealed.
This preferential direction leads to anisotropic properties related to stiffness and
strength characteristics of the tissue [4]. In the superficial zone, cartilage has higher
tensile strength, and stiffness in the direction parallel (longitudinal) to the split line
than perpendicular (transverse) to the split line [37–39]. However, it has not been
determined yet whether the AC is anisotropic or isotropic in friction or wear. We
hypothesized that cartilage will wear less in the direction parallel to the preferential
fiber orientation or split line direction than the transverse direction in an accelerated
wear test. We also hypothesized that the coefficient of friction (COF) could also
depend on the relative orientation of the fibers with respect to the direction of motion.
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2.2 Methods
Bovine stifles were collected from a local abattoir (The Old Farm, Colfax IN) and
stored at −200C before further use. Osteochondral specimen with 9.52mm diameter
and length of 18mm were collected from the femoral condyles such that articular
surface was perpendicular to the coring axis. Depending on the size of the stifles,
3-5 specimens were collected from each condyle. Locations of the sample harvest
sites were tracked by using India ink and taking proper photos (Fig:2.1). A band
saw (Skymsen, Manufacturer: Simens LTDA) was used for cutting the stifles. PBS
(Phosphate-buffered Saline) solution was applied frequently from the time the knee
was opened to the completion of the process, to keep the cartilage hydrated. A drill
press with 11 mm outer diameter drill bit was used to create a cylindrical specimen.
During drilling water was supplied continuously as a coolant. Finally, the specimens
were collected by cutting again with the band saw. Specimens were cut to a final
length of 18mm with a low speed saw (Isomet, Behler, USA). Finally, all specimens
were stored at −200C until next use.
Fiber orientation was determined by using a pin and India ink. The edge of the
cartilage was pierced in 14-16 locations and India ink was applied to the surface
of the specimens. After a few seconds the India ink fills the space in the cartilage
created by the pin. The remaining India ink was removed with dry gauze and the
fiber line was somewhat visible to the naked eye. A stereomicroscope (Stemi 508,
Zeiss) equipped with a digital camera was used to detect the fiber orientation (Fig:
2.2). Maximum aligned fibers direction was taken as direction of fiber. This fiber
direction was marked on the bone part with a carbon pencil (Fig: 2.3). Then the
cartilage was returned to PBS solution for rehydration before the experiment.
A pin on plate wear test was carried out by using Brukar Tribolab machine (Brukar
UMT Tribolab)(Appendix A). Here the osteochondral specimen was used as a pin and
a stainless-steel sheet as a plate (T316, 8# mirror finish) (Fig: 2.4 & 2.5). A hydrating
solution of PBS with protease inhibitors (1mM ethylenediaminetetraacetic acid, 5mM
12
Fig. 2.1. Picture of knee with marking the anatomic location of cartilage specimens.
13
Fig. 2.2. Split line analysis shows orientation of fiber.
14
Fig. 2.3. Specimen after complete processing and with marking of fiber direction.
15
benzamadine and 10mM n-ethylmaleimide) was used as a solution such that the
plate and cartilage were submerged in the solution (Fig: 2.4 & 2.5). An average of
22.5ml solution was used in each experiment. A 160N constant load was applied for
14000 cycles of reciprocal sliding motion with 4mm/s velocity and a travel distance
of 18mm in each direction; these parameters were determined in preliminary tests
and created visible cartilage wear in the specimens. Each wear test took 43hrs and
the total wear distance was around 504m. The total contact pressure was 2.21MPa.
A total 24 specimens were used for this analysis; 12 specimens were tested in the
longitudinal direction or parallel to the fiber direction and 12 specimens were tested
in the perpendicular direction or transverse direction to the fiber.
To quantify the angle between the fiber orientation and wear direction after the
wear test was complete, the split line analysis was conducted again on the full car-
tilages surface. Another picture was taken with the microscope equipped with a
digital camera, and average fiber angle was determined using Image J software (NIH,
USA) (Fig: 2.6). Between each experiment, the steel plate and other equipment were
cleaned thoroughly with water and dried with a paper towel and soft tissue. The
steel plate was changed when the surface was a little rough. An average of 9-10
experiments were carried out on each steel plate in three consecutive locations.
Friction and normal force ratio was taken to compute COF over the 43hrs duration
of the experiment. During analysis, COF data for acceleration and deceleration was
discarded, and only the COF data for 4mm/s velocity was considered. COF data
were averaged for each reciprocating cycle (both directions) using Matlab Software
(Mathworks, USA)(Appendix B). After taking the average COF data for complete
experiment, the first data point was considered the initial COF and because the COF
reached equilibrium after around 4hrs, the average COF of the last 39hrs was taken
as equilibrium COF.
To quantify the amount of wear of the cartilage, the solution bath was collected
after the wear test and stored at −200C before further analysis. Biochemical assays
were used to measure the amount of hydroxyproline (HYP) and glycosaminoglycans
16
Fig. 2.4. Wear test of cartilage on plate in the solution bath.
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(GAGs) released to the solution bath. HYP is an amino acid constituent and is found
almost exclusively in collagen [2].
Samples were freeze-dried (Labconco, USA) at −480C for 48hrs, collected in 1ml
activated papain digestion, and aliquots were hydrolyzed in concentrated HCl. To
quantify the amount of HYP, hydrolyzed specimens were assessed with a chloramine-
T assay [Appendix C] . To quantify the amount of GAGs, papain digested solutions
were assessed with DMMB assay [Appendix D]. Samples were diluted 10:90 ratio with
papain buffer to create 100µl sample.
Friction and wear were analyzed in the following four groups. 1) All longitudinal
and transverse samples (n = 12). 2) Only cartilage specimens that were collected
from medial condyles (n = 6). 3) Only cartilage specimens that were collected from
lateral condyles (n = 5 to 6). 4) Only those in which both longitudinal and transverse
cartilage specimens were harvested from the same knee (n = 7 to 8). For each group,
initial COF, equilibrium COF and amount of wear of the cartilage or HYP and GAGs
released in the solution bath were reported. Data was analyzed with a Students t-test,
and group 4 was analyzed with a paired t-test. Significance was set at p < 0.05.
2.3 Results
The average angle between directions of fiber and of wear for longitudinal speci-
mens was 16.1±7.5 and the average angle for the transverse specimens was 69.7±11.4.
Figure 2.6 shows the split line directions before and after the wear test.
Initially the COF was low, and with increasing time, the COF increased (Fig:2.7
a & b). After approximately 4hrs it became almost constant for the remaining 39hrs.
For the longitudinal case, the average COF increased from an initial value of 0.004±
0.001 to an equilibrium value of 0.265±0.032, and for transverse case the COF rose
from 0.00345±0.000388 to 0.248±0.0324. From the statistical analysis, no signifi-
cant differences were found between longitudinal and transverse direction for all four
groups for both the initial and equilibrium COF (Fig: 2.8A & B).
19
Fig. 2.6. a) Split line of specimen or cartilage around the edge, b)
cartilage after wear test, c) split line or fiber direction of cartilage in
the surface, d) determining the angle of the split lines or fibers.
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The amount of HYP released to the solution bath during the wear test did not
show any significant difference between the longitudinal and transverse direction of
wear of the cartilage for any of the four groups (Fig: 2.8C).
A statistically significant differences between the longitudinal and transverse di-
rection of GAGs released in the solution bath during the wear test was seen. The
differences were significant in the cases where all samples were considered, when just
the medial side was considered and when specimens from the same knees were con-
sidered. There was no significant different between longitudinal and transverse GAG
wear when specimens from just the lateral side were analyzed (Fig: 2.8D).
2.4 Discussion
Based on the amount of GAGs released in the solution bath, our hypothesis re-
garding the anisotropic nature of the cartilage tissue was supported by the accelerated
wear test. Though the specimens from the lateral condyles did not show a significant
difference, the results from the other three groups have supported our hypothesis. We
also hypothesized that the COF will be different between the longitudinal and trans-
verse direction, but no significant difference was found between the two directions of
the cartilage in the cases of initial and equilibrium COF. Results from the accelerated
wear test are consistent with reports of cartilage anisotropy in a tension test [40].
When no significant differences were seen in the HYP wear, it was assumed that
there might be a difference between the AC collected from the lateral side and the
medial side. Therefore, AC collected from the medial and later side were analyzed
separately. Moreover, different donor ages, origins or health conditions might cause
different AC structure. Therefore, the wear test for the same knee was analyzed, where
both samples were harvested from the same donor. However, none of these analyses
have shown difference in HYP wear in the longitudinal or transverse directions. While
the amount of GAGs released to the hydrating bath due to wear was different between
the longitudinal and transverse specimens, differences in the HYP wear were not
22
Fig. 2.8. A) Initial COF measurement taken immediately upon onset
of the testing, B) Equilibrium COF measured at the end 43hrs testing,
C) HYP that was removed from the tissue during wear, D) GAGs that
were removed from the tissue during wear.
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detected. It is possible that the collagen network was more damaged in transverse
wear than longitudinal wear but was not released to the solution bath completely.
Damaged collagen could stay attached to the cartilage surface, while the GAGs release
to the solution bath. In the future, differences in collagen fiber damage in longitudinal
and transverse wear specimens may be detected by using collagen hybridizing peptide
[41].
The average fiber angle for longitudinal and transverse direction was not exactly
00 or 900. The specimens were aligned using the fiber angles that were determined at
the edges, but after the wear test more data on the fiber angles was collected across
the cartilage surface. Because the fiber angle varies across the surface, the preferential
direction that was determined after the wear test was not the same as the one that
determined before the test started and was used to align the test specimen. This lead
to a deviation in the angle between wear and fiber lines from 00 or 900 (Fig:2.6C).
Besides that, the specimens were aligned in the wear test manually, which lead to
some experimental positioning errors. In spite of this, the angle was close to 00 or
900 with an average deviation within 200.
Initially the COF increased rapidly, but after time it became almost constant.
During the wear test, the load is initially carried by the fluid pressure. With increasing
time, the fluid leaves the AC, the load transfers from the fluid to the solid matrix and
the COF increases. In the equilibrium condition, fluid flow stops and the solid matrix
carries its maximum load. The fluid does not create frictional forces, so initially the
frictional force is low because the load is mainly carried by the fluid. By the time, the
COF increases as the load is transferred from the fluid to the solid and is a maximum
at equilibrium. This COF behavior was seen by many other groups and our result is
consistent with their reports [20,42–44].
Significant differences in GAGs released to the hydrating bath during the wear
test may be helpful in improving grafting treatments. The results suggest that the
orientation of full-thickness tissue grafts will affect wear, and if oriented such that the
fibers are transverse to joint articulation they will wear more. Surgeons may need to
24
pay attention to the fiber orientation of the grafts. This result is also important for
the biomechanical engineers that are performing an in vitro wear test. They should
be careful about the orientation of the cartilage to conduct a consistent wear analysis.
25
3. EFFECT OF ANATOMIC LOCATION ON CARTILAGE
ON WEAR RESISTANCE
3.1 Introduction
From different studies, it has been found that when people exercise regularly their
cartilage becomes stronger than the cartilage of peoples who do not. Regular exercise
and walking will increase the proteoglycan content and compressive stiffness, decrease
the rate of fluid flux during loading and reduce the probability of OA [6,45,46]. This
may be due to the increased mechanical load to the cartilage, as mechanical loading
enhances cartilage matrix production. Generally, the medial side of the knee joint
carries more of the body mass than the lateral side [47]. The knee joint AC doesnt
come in contact uniformly during movement. Due to knee anatomy, the middle
portion of the knee takes the maximum load or contact pressure during movement,
whereas other areas take much less. We have hypothesized that the cartilage in the
middle of the medial condyle or load bearing zone takes maximum pressure during
movement and as a result, the AC in that zone is stronger than the other zones
and will have better wear resistance. So, the cartilage from the condyles in the
bovine knee were divided in four zones, 1) distal from middle of medial, 2) middle
of medial, 3) middle in lateral, and 4) distal from middle of lateral. In this study,
an accelerated wear test of cartilage was carried out on specimens from those four
zones and the amount of wear was measured. The amount of hydroxyproline (HYP),
glycosaminoglycan (GAGs), DNA (cellular content) and water content of adjacent
cartilage samples were quantified to compare the composition of the cartilage in those
four locations. This study would be beneficial to medical science if it could show which
anatomic locations were the best sources of tissue for transplants.
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Fig. 3.1. Bovine knee with four locations identified.
3.2 Methods
Using the same technique as described in Chapter 2, 28-osteochondral cylindrical
specimens were collected from seven knees, with four specimens from each knee (Fig:
3.1). To maintain consistency, the split line on the edge of the cartilage specimens
was found in 14-16 different locations and the fiber direction was determined. An
accelerated, in vitro, reciprocal wear test was carried out for all the samples using the
same protocol as described in chapter 2 (14000 cycles, 160N load, 4mm/s velocity,
18mm travel distance in each direction) with the direction of travel oriented in the
direction longitudinal to the preferred fiber orientation.
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To quantify the amount of wear of the cartilage, the solution bath was collected
after the wear test and stored at −200C before further analysis. Chloramine-T and
DMMB assays were used to measure the amount of HYP and GAG content in the
solution bath, respectively [Appendix C & Appendix D].
Cartilage that had been adjacent to the wear test specimens were collected from
three of the knees or 12 of the specimens. At each site, three to four full thickness
cartilage samples were collected using a surgical blade and stored at −200C before
further analysis.
In each location, adjacent cartilage samples were divided in two groups, full thick-
ness cartilage and superficial zone cartilage. For the superficial zone, 250 µm thickness
of the cartilage was taken off from the articular surface using a sledge microtome (Mi-
crom GmbH HM430, Germany) of one to two cartilage samples from each location
and the remaining one to two cartilage samples were used in full thickness.
The mass of the samples were taken before and after freeze-drying. HYP (collagen)
content was assessed through a Chloromine-T analysis [Appendix C], GAG content
was quantified through a DMMB analysis [Appendix D], and cellular content was
evaluated by quantifying the amount of DNA through the PicoGreen kit (Appendix
E; Invitrogen, CA, USA) following the manufacturers protocol.
For HYP analysis in full thickness and superficial zone, 10µl and 50µl papain
digested solution, respectively, were used. This was less than the normal protocol
(Appendix C) because the amount of HYP in full thickness or superficial zone was
otherwise beyond the assay limits. For GAGs analysis in full thickness and superficial
zone, 2.5µl and 5µl papain digested solution or stock solution, respectively, were used,
and diluted to a final volume of 100µl.
For measuring water content as a percentage the following formula was used (3.1),
%Water content =
Wet cartilage weight−Dry cartilage weight
Wet cartilage weight
× 100% (3.1)
Total HYP, GAGs, and DNA content were reported normalized to wet weight. The
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following comparison among the four locations were analyzed: a) HYP released to the
solution bath during wear test, n= 7 per location, b) GAGs released to the solution
bath during wear test, n= 7 per location, c) HYP normalized to wet weight in the full
thickness and superficial zone of the cartilages, n= 3 per location, d) GAGs normalized
to wet weight in the full thickness and superficial zone of the cartilages, n= 3 per
location, e) DNA normalized to wet weight in the full thickness and superficial zone
of the cartilages, n= 3 per location, f) % water content in the full thickness of the
cartilage, n= 3 per location. One-way ANOVA with repeated-measures with Tukeys
post-hoc analysis was performed with GraphPad Prism software.
3.3 Results
3.3.1 Comparison of Wear Test Results
Quantification of HYP and GAGs released to the solution bath during the wear
test have not shown any significant difference among the four locations (Fig: 3.2A &
C). When looking at the HYP and GAGs released in the solution for each individual
donor, no specific pattern is evident (Fig: 3.2B& D). It was expected that average
wear might lowest in middle position of the medial side, but in some donors the wear
at this location is the highest.
3.3.2 Comparison of Compositions in Four Locations
Comparison of HYP, GAGs, DNA content & % of water content among the four
locations were analyzed for full thickness and superficial zone of the cartilage. No
significant differences were seen between the different locations for any of the con-
stituents of cartilage that we measured (Fig: 3.3).
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Fig. 3.2. A& C) Average amount of wear in terms of HYP & GAGs
released in the solution bath for the four locations, B &D) Amount of
wear for four locations samples for each donor in terms of HYP and
GAGs released to the solution bath.
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Fig. 3.3. HYP content (A-B), GAG content (C-D), DNA content
(F-G) and water content (E) in the full thickness (A, C, E, F) or
superficial zone (B, C, G) of the cartilage in four specific locations.
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3.4 Discussion
It was hypothesized that cartilage from different anatomic locations would give
different wear and composition based on different loading. Our hypothesis is not
supported by the experimental results. No significant differences were found among
the four locations in terms of amount of wear or cartilage compositions. There may
not be a large difference in the loading at the different sites that we tested. The
congruent shapes of the articular cartilage may distribute the load relatively evenly
to different sites, leading to consistent composition throughout the articular joint.
Another reason could be that samples were harvested from the flattest locations of
the femoral condyle. This flat surface maintains a consistent contact pressure between
cartilage and the steel plate for all specimens. However, the flat surfaces may take
a similar load to one another. For that reason, any significant differences might not
be acquired in the wear and the composition of cartilage among the four locations.
Our results are consistent with measurements of the shear and aggregate moduli of
the cartilage from the medial and lateral condyles of the human knee [48], which also
did not differ with anatomic location.
S. Akizuki et al. had shown that cartilage from the lower weight bearing area had
a higher tensile modulus than the cartilage from the higher weight bearing area of
the human knee joint [39]. They have also shown that cartilages from lower weight
bearing site had a higher collagen/proteoglycan ratio than the higher weight bearing
site. Poissons ratio and stiffness were also reported to be higher in the cartilage from
femoral medial condyle than the femoral lateral condyle for the canine and human
knee [48,49]. These properties, such as tensile modulus and Poissons ratio, may not be
related to wear resistance. Moreover, in S. Akizukis studies, higher and lower weight
bearing sites had large distances between the two locations [39]. In our studies, all
four harvest sites were on the condyles (Fig:3.1). This may also explain why we did
not observe any significant differences in the wear or biochemical composition in the
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four locations. Due to different testing procedures, different species, and different
harvest sites, our results are not similar to these previous studies.
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4. ANALYSIS OF CARTILAGE COMPOSITION IN
RELATION TO WEAR AND FRICTION
4.1 Introduction
Different cartilage specimens showed different amounts of wear in the accelerated
wear test. For example, in Chapter 3, the standard deviation of HYP wear was more
than 25% of the average value (Fig: 3.2A). To better understand cartilage wear, it
would be helpful to understand whether variations in the composition of the cartilage
can explain the variations in wear. The main components of cartilage are collagens,
proteoglycans, cells and water. Previous studies have determined that mechanical
properties vary with the cartilage composition. For example, tensile strength is cor-
related with the water, collagen, and pyridinoline content [29], tensile modulus is
correlated with collagen/proteoglycan ratio [39], and Poissons ratio is correlated with
hydroxyproline/uronic acid ratio [49]. However, it has not been determined, whether
the friction and wear is also correlated with cartilage composition.
The correlations between friction and wear quantities and cartilage composition
were analyzed. The friction and wear quantities that we assessed were initial COF,
equilibrium COF, friction slope and time constant, HYP wear, and GAG wear. Since
wear occurs at the articular surface, the composition of the superficial zone may play
an important role in the wear. Therefore, the composition of both the superficial zone
and full thickness of cartilage samples that were adjacent to the wear test specimen
were evaluated. Correlations between the friction/wear parameters and cartilage com-
position were determined. This information could help predict the wear of allograft
and autograft tissues based on their composition.
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4.2 Methods
For this analysis, 14 osteochondral cylindrical specimens were collected with 9.52mm
diameter from three knees for accelerated wear testing. Moreover, we also collected
three to four samples of cartilage that were adjacent to the wear test specimens.
All wear test specimens and adjacent cartilage samples were stored in the freezer at
−200C before further analysis.
To maintain consistency, the split line analysis was performed at the edge of the
cartilage in 14-16 different locations and the fiber direction was determined. The wear
test was carried out for all of the samples(n=14) using same protocol as described in
Chapter 2 (14000 cycles, 160N load, 4mm/s velocity, 18mm travel distance on each
side) with specimens oriented in the longitudinal direction.
The amounts of HYP and GAGs released in the solution bath due to the wear
test were quantified as described in Chapter 2. Friction and normal force was taken
to calculate the COF, also as described in Chapter 2.
The COF rises initially and reaches equilibrium at about 4.5 hours. To charac-
terize this transient behavior, coefficients A and B of an exponential curve were fit
to the COF data for 4.5hrs, using Matlab (Mathworks, USA), with initial coefficient
values of A0 = 0.5 and B0 = 0.5.
COF = A× (1− expBt) (4.1)
where t is time. The initial slope of COF with respect to time was found by taking
the derivative of the exponential equation and setting the time to zero.
Slope = A×B (4.2)
The time constant (τ) of equation (4.1) is
τ = 1/B (4.3)
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Fig. 4.1. Diagram of correlations among different wear and friction
properties of cartilage and cartilage composition.
Cartilage compositions of the adjacent samples were analyzed with the same pro-
tocol as described in Chapter 3. A total of 28 samples for 14 locations were examined;
14 cartilage samples for the full thickness analysis and 14 cartilage samples for the
superficial zone analysis. To quantify the content of HYP, GAGs, DNA and water,
the same protocols were used as described in Chapter 3 and HYP, GAGs, and DNA
data were reported as normalized to wet weight.
Correlation analysis were conducted between different components of cartilage
composition and friction or wear (Fig: 4.1) using GraphPad Prism Software with
p < 0.05 considered as significant.
The results were reported with graphs showing the amounts of particular com-
ponents of cartilage composition on the y-axis and the values of the friction or wear
properties on the x-axis for each specimen(Fig: 4.2).
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Fig. 4.2. A schematic of correlation analysis.
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Fig. 4.3. Diagram of correlation among different friction and wear
properties of cartilage.
Alternately, correlations were conducted between different measures of friction
and wear (Fig:4.3), also using GraphPad Prism Software with p <0.05 considered as
significant.
4.3 Results
4.3.1 Best Fit Curve Between COF and Time
The exponential equation fit the COF vs. time data well, with R2 values all above
0.94 (Fig:4.4). Average values for A and B were 0.2943 and 0.0005s−1 respectively.
4.3.2 Correlation Between Measures of Friction and Wear vs. Cartilage
Composition
From the linear regression analysis, there was a significant correlation between the
wear and the full-thickness collagen content. The HYP released to the fluid during
the wear test and HYP content of the full thickness of the cartilage were a negatively
38
Fig. 4.4. Typical best fit curve for COF vs Time data.
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correlated (Fig: 4.5a). Similarly, the GAGs released to the hydrating fluid during the
wear test was also negatively correlated with the collagen content in the full thickness
of the cartilage (Fig: 4.5f).
There was also another trend between HYP wear and % of water content in the
full thickness of the cartilage (p = 0.0599). The slope was negative, and the line was
nearly flat. (Fig: 4.5e)
The initial COF tends to correlate with HYP content in the superficial zone of
the cartilage (Fig: 4.5i). So, lower amount of HYP in the superficial zone increase
the initial COF (p= 0.0034). We have not found any other correlation between the
friction and wear parameters with the cartilage composition.
DNA content was not correlated to anything, so it is not shown in the figure.
4.3.3 Correlation Graphs Between Measures of Friction and Wear
A positive tendency was found between the friction time constant and HYP wear
(p = 0.0654; Fig: 4.6a). A significant negative correlation was found between slope of
COF and HYP removed from the tissue in the wear test (Fig: 4.6e). Time constant
and equilibrium COF also correlated significantly; they are correlated positively (Fig:
4.6d). The HYP and GAG wear are positively correlated with each other (Fig: 4.6m).
We have not found any other significant correlation among the other groups.
4.4 Discussion
Previous studies have determined a relationship between composition and mechan-
ical properties of cartilage. T. Lyrra et al., A.K. Williamson et al., and J.S.Jurvelin
et al. had studied the relationship between the cartilage composition and equilibrium
modulus, tensile strength, and Poissons ratios [29,48,49]. Significant correlations have
also been found in the current study between biochemical composition, friction and
wear in a standardized accelerated wear test. For example, wear and collagen content
in the full thickness of the cartilage was negatively correlated; lower HYP content
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Fig. 4.7. Correlation between HYP content in the full thickness(FT)
of the cartilage and HYP removed from the tissue during the wear
test.
leads to a higher amount of wear (Fig: 4.7). As HYP is an amino acid component
of type II collagen network, less of the type II collagen network leads to a higher
amount of wear. A reduced collagen network has less strength, and as a result, it is
more easily broken down in the accelerated wear test. In contrast, a higher amount
of HYP or collagen network does not break down easily, and as a result, it wears
less. The additional significant correlation between GAG wear and collagen content
of the full thickness of the cartilage confirms the idea that a lower amount of type
II collagen network leads to a higher amount of wear in accelerated wear test. Both
results indicate that a higher amount of wear of the cartilage may be due to the lower
amount of HYP or collagen in the full thickness of the cartilage.
43
Another correlation has also been observed between HYP removed from the tissue
during the wear test and water content in the full thickness of the cartilage. The
water content among all specimens is almost constant, so the correlation may not be
meaningful.
Another significant negative correlation has been found between initial COF vs
HYP content in the superficial zone, meaning that higher HYP content in the su-
perficial zone creates lower initial COF whereas lower HYP content in the superficial
zone creates higher initial COF. Higher HYP/collagen content in the superficial zone
might be able to constrain higher amounts of fluid pressure than the cartilage with
lower HYP, and more fluid pressure leads to lower initial COF.
Moreover, GAG and HYP wear are also directly correlated (Fig: 4.6m). The
type II collagen network holds the GAGs in the cartilage tissue. So, if this collagen
network is damaged, then GAGs release from the cartilage.
A significant positive correlation has been found between friction slope and HYP
wear. This seems counterintuitive, because higher slope means the COF rises faster,
and as a result, it should give more wear than the cartilage with lower slope. However,
intuition would also suggest that higher friction leads to more wear, but there was
no correlation that would support this. This suggests that the relationship between
friction and wear in cartilage is complicated and may not follow intuition. There
are also other properties, like permeability, that may be responsible for the transient
frictional behavior.
This analysis may be helpful in improving the surgical grafting procedure. Before
allograph or autograph of cartilage tissue is transplanted, the HYP content in the
cartilage should be analyzed. Cartilage with lower HYP content in the full thickness
and superficial zone of the cartilage should not be used as this will be associated with
higher wear and higher friction.
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5. CROSSLINKING OF CARTILAGE TISSUE TO
IMPROVE RESISTANCE DUE TO WEAR
5.1 Introduction
High trauma to the cartilage surface due to accident causes cartilage fissures and
micro damage [50, 51]. A high energy trauma to the AC surfaces causes a mechani-
cal, biochemical and cellular response that can lead to post traumatic osteoarthritis
[PTOA]. A single traumatic event can generate pro-inflammatory cytokines that cause
an upregulation of degenerative enzymes that leads to reduce mechanical properties
and ultimately wear resistance [52–55]. An AC injury can also cause microstructural
damage with or without creating fissures [56]. PTOA often leads to joint replacement.
But for younger individuals, arthroplasty is not an effective option, due to limited
life span of the implants [57–59]. Present surgical treatment for joint injury, such as
anatomic reduction of intra-articular fractures, ligament repair, and joint stabilization
can improve joint instability or incongruity, but do not repair the mechanical damage
of the AC surfaces [60–66]. Recent studies have shown that chondrocyte damage due
to mechanical overload can be limited by biological therapies, they also prevent the
consequent activation of catabolic pathways. For example, D′Lima et al. showed that
a caspase inhibitor reduces degradative chondrocytes pathways [67] while Haut et al.
showed that cellular necrosis due to mechanical insult to cartilage tissue is reduced
by surfactant [68]. That antioxidants are effective for reducing chondrocyte death
was reported by Martin et al. [69, 70]. However, while these analyses are promis-
ing biological treatments, they do not repair the mechanical responses or mechanical
integrity.
In previous studies, collagen crosslinking using genipin, a natural plant extract,
improved mechanical properties like stiffness and wear resistance of cartilage [27]. So,
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our long-term goal is to induce exogenous crosslinks to the collagen network to prevent
wear and degradation in damage articular cartilage. But, higher concentrations of
genipin causes chondrocytes death [21]. Besides that, genipin treatment is difficult to
apply in specific locations because the genipin solution will crosslink all the tissues
that it contacts in the joint. Photo-initiated crosslink protocols have been developed
by using chloro-aluminum phthalocyanine tetrasulfonic acid (CASPc) with 670nm
laser light [71,72]. This laser light interacts with CASPc to cause an oxidation reaction
that crosslinks the collagen network. Due to this crosslink the bond among the
collagen fibers increases. This treatment can be used in a specific location of joints,
because in this process only the location that is exposed to light will be crosslinked. In
this analysis, two protocols were used. The first protocol was first reported by another
group; a crosslinked bond was created at the interface between two cartilage tissues for
the purpose of adhering a graft to the cartilage surrounding a defect site [73]. Whether
this protocol can be used to improve the mechanical wear response of cartilage is
currently unknown. Moreover, in their protocol, the laser exposure time was larger
than the time that the tissue is submerged in the CASPc solution. But, as a treatment
for PTOA, less laser time will be more convenient to the doctor and the patient.
Therefore, a second protocol was developed that reduced laser exposure time and
increased CASPc submersion time. The second protocol was optimized previously
by indentation test in our lab. The objective of this study was to test both the
photochemical crosslinking protocols in an accelerated wear test of the cartilage.
5.2 Methods
For this analysis, a total 27-osteochondral cylindrical specimens with 9.52mm
diameter were collected from four knees using same protocol as describe in chapter
2. Those samples were stored in the freezer at −200C before further analysis.
The wear test was carried out in three different groups, two treated groups and
one untreated group. Additionally, in a control group, zero load was applied, and
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other protocols remained same as in Chapter 2 (n=3). During processing, cartilage
specimens were cut using different tools to get the cylindrical specimens. As a result,
during the wear test some collagen was released in the solution bath through the
cut surfaces. So, this amount of collagen released in the solution bath in the control
group is consistent for all groups but does not come from cartilage wear.
For treated groups, a total ten specimens were used, five specimens for each group.
First, the specimen was removed from the freezer and rehydrated in PBS solution
for 15min before the crosslink treatment. For crosslinking, 2ml 0.5mM CASPc was
prepared. For getting stable laser power, the laser power (current 0.82A) was kept
on for 30min before laser exposure.
In the first protocol, the specimen was submerged in the 0.5mM CASPc solution
for 20s. After that, the articular surface immediately was exposed to laser light
covered with plastic wrap for 10 minutes. The laser power was 265mW and the spot
size diameter was around 5.5mm (Fig: 5.1). The plastic wrap was used on the top
of the specimen to keep the cartilage hydrated. After the laser treatment, a photo
was taken of the crosslinked cartilage using a stereomicroscop equipped with a digital
camera, then the cartilage was submerged in PBS for rehydration and equilibration
at the room temperature. The wear test was carried out by using same protocol as
described in the chapter 2.
In the second protocol, the specimen was submerged in the 0.5mM CASPc for
20min and the laser treatment was 2min. Other procedures were the same as in the
first protocol.
In the untreated group, a total of fourteen specimens were used, and wear test
was carried out by using same wear test protocol as in Chapter 2, without laser and
without CASPc.
After the wear test the solution bath was collected in the freezer at −200C before
further analysis. To quantify the amount of HYP wear, the same steps were taken as
in Chapter 2 and Appendix C.
Initial COF and equilibrium COF were reported as described in Chapter 2.
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The average HYP released to the water bath from the control group was subtracted
from the other groups to give the HYP in the bath that was only due to the wear.
One way ANOVA followed by LSD post hoc test was carried out with SPSS soft-
ware to evaluate statistical differences in the mean Initial COF, Equilibrium COF and
HYP wear of the three groups (Untreated, Crosslink protocol-1, Crosslink Protocol-
2).
5.3 Results
Specimens with both crosslink treatments showed significantly lower wear than
the untreated specimens (Fig:5.2). In the post hoc test, statistically significant dif-
ferences were found between untreated and crosslink protocol-1, and untreated and
crosslink protocol-2. However, no differences were found between crosslink protocol-1
& crosslink protocol-2 (Fig: 5.3C). Initial and equilibrium COF were not significantly
different among the 3 groups in the one-way ANOVA analysis (Fig: 5.3A & B).
5.4 Discussion
The wear resistance of the cartilage increased due both crosslinking treatments.
The first crosslinking protocol was used by Arvayo et al., where strength of a crosslinked
bond was analyzed between graft and host cartilage [73], and was used in the accel-
erated wear test.
In our lab, different combinations of laser timing and submerging time of cartilage
in CASPc was first analyzed with an indentation test. The indentation test charac-
terizes the mechanical and viscoelastic properties of the cartilage tissue [74, 75]. A
constant indentation depth or stress relaxation test can be useful for AC because its
mechanical response changes as a function of time [72]. In this technique, maximum
load will be achieved just as the maximum indentation depth is reached, after that
load will reduce and will eventually become equilibrium [76].
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Fig. 5.1. Laser treatment of the cartilage.
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Fig. 5.2. Cartilage after the wear test a) untreated, b) treated with
Crosslinking protocol-1 b) treated with Crosslinking protocol-2.
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Fig. 5.3. A) Initial COF, B) Equilibrium COF, C) HYP due to wear
of untreated and, two treatment groups (Crosslink protocol-1 & 2).
*Indicates significant difference from untreated.
51
Fig. 5.4. Indentation test result for untreated, crosslink protocol-1
& 2. Results are shown as max load after crosslinking divided by
max load before crosslinking. [Wagner Lab]. *Indicates significant
difference from untreated.
From the indentation test result, no significant difference was found between the
crosslink protocol 1 and 2, and both protocols were stiffer after crosslinking, compare
to the untreated specimens (Fig: 5.4). From this analysis, crosslink protocol-2 was
chosen with minimum laser time. In the accelerated wear test, the crosslink protocol-2
has also given higher wear resistance of cartilage than the untreated group. No sig-
nificant difference was found between crosslinking protocol 1 & 2, which is consistent
with the indentation test result.
No significant differences have been observed between untreated and treated group
in frictional analysis. So, these crosslink protocols have not changed any frictional
properties of the cartilage tissue. Bonitsky et al. had not found any significant differ-
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ences in friction of cartilage tissue with genipin crosslinking treatment [27]. Moreover,
Sitterle et al. had reported that photochemical treatment with CASPc does not cause
cell death [35].
One limitation of our analysis that the diameter of the laser light was 5.5mm,
whereas the diameter of the specimen or cartilage surfaces was 9.52mm. For that
reason, the crosslinking treatment was carried out in a smaller area or in the middle
of the cartilage instead of the full surfaces and during wear test some wear was
observed in the untreated area surrounding the location of laser light (Fig: 5.2b &
c). If a larger laser spot size could be applied, it might give a better result.
This finding may be important in the treatment of impacted AC. Doctor may be
able to use CASPc crosslinking treatment to improve the wear resistance properties
of the AC to prevent or slow down the progression of cartilage damage. In addition,
crosslink protocol-2 is more convenient to apply during treatment than the crosslink-
ing protocol-1 because the doctor would not need to hold the laser light for as long
of time.
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6. CONCLUSION AND FUTURE DIRECTIONS
6.1 Conclusions
One limitation in our analysis is that the wear test is an accelerated wear test and
is not physiologic. In real life, cartilage does not experience a large, constant load
for a long period of time, nor does it experience significant wear during a 43 hours
time period. During walking or running, the maximum load occurs for short period of
time and then the load releases; water exudation and re-absorption occur cyclically.
Despite this limitation, the studies in this thesis describe various factors that affect
the wear of bovine articular cartilage in accelerated testing in vitro. In Chapter
2, the hypothesis regarding the anisotropic nature of cartilage wear was proven by
quantifying the GAGs released to the hydrating fluid. The COF of the cartilage tissue
did not show any anisotropic behavior in the accelerated wear test. In Chapter 3,
no significant differences in wear were seen between the anatomic locations that were
tested. In Chapter 4, a significant negative correlation has been found between HYP
wear and HYP content in the full thickness of the cartilage, and between GAG wear
and HYP content in the full thickness of the cartilage. Another significant correlation
had been observed between initial COF and HYP content in the superficial zone of
the cartilage. No other interesting correlation has been observed between friction
properties and wear quantities and composition of the cartilage. In Chapter 5, the two
photo-initiated crosslinking protocols have given better wear resistance in cartilage
tissue without changing the frictional behavior of the cartilage.
54
6.2 Future Directions
While these studies have uncovered some important relationships between the
orientation, composition, and degree of crosslinking with the wear and friction of
cartilage tissue, open questions remain. For example, a significant difference has
been found between the longitudinal and transverse directions in GAG wear but not
in HYP wear (Chapter 2), even though HYP and GAG wear are positively correlated
(Chapter 4). So, to quantify wear, it may be important to analyze both the HYP
and GAGs release during the wear test. Furthermore, the use of collagen hybridizing
peptides should be considered to quantify the amount of damaged collagen remaining
on the cartilage specimen.
Although some significant correlations were found between cartilage composition
and measures of friction and wear, other material properties of cartilage may also
determine the friction and wear characteristics. For example, permeability and native
collagen crosslinks may partially determine the friction and wear properties.
In the future, after damaging the cartilage with an impact load, the photochem-
ical crosslinking treatment will be applied to the damaged cartilage. The wear test
will be carried out with the impacted and treated cartilage. This will help us to
understand the effect of photochemical crosslinking treatment for the post traumatic
osteoarthritis(PTOA) patients.
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A. TRIBOLAB WEAR TEST CODE
<?xml version="1.0" encoding="UTF-8"?>
<UMT>
<!--Script-->
<ScriptVersion CtsxVersion="1"/>
<ScriptBinder AltUnit="" ChannelsToSave="Fx;Fz;Z3;V3"/>
<Sequences index="0" IsSelected="1">
<TakeoffItem>
<TouchForce Value="0.200000"/>
<PretouchSpeed Value="1.000000"/>
<TouchSpeed Value="0.100000"/>
</TakeoffItem>
<AutopilotItem>
<TolerancePlus Value="0.020000"/>
<LoopExternal>
<ParamDefault Value="1"/>
</LoopExternal>
</AutopilotItem>
<LandingItem/>
<BlackboxItem>
<DataFileName Value="C:\file location\file name.tst"/>
<FilterSize Value="15"/>
<ChannelNames>
<Value index="0" value="Fx"/>
<Value index="1" value="Fz"/>
<Value index="2" value="Z1"/>
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<Value index="3" value="Z2"/>
<Value index="4" value="Z3"/>
<Value index="5" value="V1"/>
<Value index="6" value="V2"/>
<Value index="7" value="V3"/>
</ChannelNames>
<ChannelUnits>
<Value index="0" value="N"/>
<Value index="1" value="N"/>
</ChannelUnits>
</BlackboxItem>
<NameItem>
<SequenceName Value="Apply Load"/>
</NameItem>
<Steps index="0">
<CarriageItem>
<Force1 Value="160.000000"/>
<Duration Value="5.000000"/>
<ParameterDur>
<ParamDefault Value="5.000000"/>
</ParameterDur>
<ForceProfile/>
<FocusingDist Value="2.000000"/>
<TargetLocation Value="1"/>
<OscPID_I Value="0.000100"/>
</CarriageItem>
<Spindle1Item/>
<Spindle2Item/>
<SliderItem/>
64
<NameItem/>
<StrainItem/>
<HeaterItem/>
<PumpsItem/>
<CP4Item/>
<PowerSupplyItem/>
<PiezoItem/>
<XYSynchItem/>
</Steps>
</Sequences>
<Sequences index="1" IsSelected="1">
<TakeoffItem>
<TouchForce Value="0.200000"/>
<PretouchSpeed Value="2.000000"/>
<TouchSpeed Value="1.000000"/>
</TakeoffItem>
<AutopilotItem>
<TolerancePlus Value="0.020000"/>
<LoopExternal>
<ParamDefault Value="1"/>
</LoopExternal>
</AutopilotItem>
<LandingItem/>
<BlackboxItem>
<CreateDataFile Value="1"/>
<DataFileName Value="C:\file location\file name.tst"/>
<FilterSize Value="15"/>
<ChannelNames>
<Value index="0" value="Fx"/>
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<Value index="1" value="Fz"/>
<Value index="2" value="Z3"/>
<Value index="3" value="V3"/>
</ChannelNames>
<ChannelUnits>
<Value index="0" value="N"/>
<Value index="1" value="N"/>
</ChannelUnits>
</BlackboxItem>
<NameItem>
<SequenceName Value="Reciprocating Test"/>
</NameItem>
<Steps index="0">
<CarriageItem>
<Force1 Value="160.000000"/>
<Duration Value="43.500000"/>
<ParameterDur>
<ParamDefault Value="156600.000000"/>
</ParameterDur>
<TimeUnit Value="2"/>
<MoveUpAtEnd Value="1"/>
<ForceProfile/>
<FocusingSpeed Value="0.200000"/>
<FocusingDist Value="2.000000"/>
<TargetLocation Value="1"/>
<OscPID_I Value="0.000100"/>
<AbortSpeed Value="1.000000"/>
</CarriageItem>
<Spindle1Item/>
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<Spindle2Item/>
<SliderItem>
<Distance Value="18.000000"/>
<ParameterOffset>
<ParamDefault Value="18.000000"/>
</ParameterOffset>
<MotionType Value="4"/>
<CycleDelay2 Value="1.000000"/>
<Speed Value="4.000000"/>
<ParameterSpeed>
<ParamDefault Value="4.000000"/>
</ParameterSpeed>
<CyclesCount Value="14000"/>
<CycleDelay1 Value="1.000000"/>
</SliderItem>
<NameItem/>
<StrainItem/>
<HeaterItem/>
<PumpsItem/>
<CP4Item/>
<PowerSupplyItem/>
<PiezoItem/>
<XYSynchItem/>
</Steps>
</Sequences>
<SGUIParameters/>
</UMT>
67
B. MATLAB CODE FOR AVERAGE COF CALCULATION
clear all
clc
data = xlsread(’F:file directory.xlsx’);
a = data(:,5);
b=zeros(596,1);
j=1;
sum=0;
for i = 1:596670;
sum=sum+a(i);
if i==1000*j
b(j) = sum/1000;
sum=0;
j=j+1;
end
end
disp(b);
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C. PAPAIN DIGESTION
C.1 Papain Buffer (PB, can be stored at RT)
To make 10 ml of PB:
1. 10 ml DI H20
2. 100 l EDTA
3. 156 mg Sodium phosphate, monobasic dihydrate
4. pH to 6.5
C.2 Activated Papain Solution (make fresh)
To make 10 ml Activated Papain Solution
1. Add 8.8 mg L-Cysteine to 10 mL PB
2. Calculate volume of papain needed:Requires 125 µg/ml final papain concentra-
tion. *Note that the stock papain concentration changes from batch to batch.
Update any calculations based on the current lot of papain. Total= 125µg/ml *
10ml = 1250µg = 1.25mg Stock Papain = 21 mg/ml Therefore (1.25/21) * 1000
= 59.52 µl
3. Remove papain from bottle using sterile syringe in hood and place in a 500 µl
tube
4. Remove from hood and add calculated volume of papain to Activated Papain
Solution
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C.3 Papain Digestion
1. Add Activated Papain Solution to each sample in a 1 ml tube
2. 1 ml per cartilage explant
3. Place tubes in a 600C water bath overnight
4. The next morning, place tubes in oven at 800C for 15 minutes
5. Samples can be stored at −800C until use for future biochemical assays
C.4 Hydroxyprolin Assembly
Hydrolyzation & Neutralization procedure for media:
1. Prepare samples/PB (100 l) in 0.5 ml O-ringed screw capped micro-centrifuge
tubes.
2. Add 100 µL of concentrated HCL (38%) to each tube.
3. Seal the micro-tube, vortex and spin briefly using the bench-top centrifuge.
4. Incubate at 1100C for 18 hours.
5. After cooling, centrifuge the micro-tubes at 10000g for 5 mins.
6. Dry the samples in a heating block at 600C in a fume hood with the lids off.
Usually takes 48-72 hours.
7. Dissolve in 200 µL ultra-pure H2O.
8. Vortex until re-suspended, and spin the micro-tubes using the small bench-top
centrifuge.(For the lower concentration samples, e.g. day 0, there may be some
sediment which wont re-suspend, in this case, centrifuge this sediment to the
bottom of the tube with bench-top centrifuge and take sample from top of tube,
taking care to avoid the sediment.)
9. Samples can be analysed immediately or stored at 40C for up to 1 week.
70
C.5 Hydroxyprolin Stock Solution
1. Add 40 mg of trans-4-Hydroxy-L-proline (56250, Fluka) to 40 ml of ultra pure
H20 to create 1 mg/ml stock solution.
2. Label and store at 40C.
3. Solution expires after 3 months.
C.6 Citrate Stock Buffer
1. Prepare 100 ml of solution: Use fresh batch for each experiment.
• 80 ml Ultra pure H20
• 5.04 g Citric acid monohydrate (C1909, Sigma, MW 210.14)
• 11.98 g Sodium acetate trihydrate (S7670, Sigma, MW 136.08)
• 7.22 g Anyhdrous sodium acetate (71183, Sigma, MW 82.03)
• 3.4 g Sodium hydroxide (M137, Amresco, MW 40)
• 1.26 ml Glacial acetic acid (42322-5000, Acros)
2. Adjust pH to 6.1.
3. Add ultra pure H20 to bring total volume to 100 ml.
4. Filter with filter paper (09-790-4B, Fisher).
5. Label and store at 40C.
C.7 Assay Buffer (per 2 plates)
Prepare fresh in a 15 ml Falcon tube before assay by dissolving:
• 1.5 ml 1-propanol (43848, Alfa-Aesar)
• 1 ml ultra pure H20
• 5 ml citrate stock buffer
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C.8 Choloramin T Reagent (per plate):
1. Prepare fresh in a 15 ml Falcon tube before assay by dissolving:
• 141 mg Chloramine T (857319-100g, Sigma, MW 227.6)
• 0.5 ml ultra pure H20
2. Place in oven at 600C for 10 min to dissolve. Then add:
• 0.5 ml 1-propanol (43848, Alfa-Aesar)
• 4 ml citrate stock buffer
3. Wrap the tube in tinfoil until use
C.9 DMBA Reagent (per plate)
1. Prepare fresh in a 15 ml Falcon tube before assay by mixing:
• 6 ml 1-propanol (43848, Alfa-Aesar)
• 3 ml 70% perchloric acid (2766-14, Macron)
C.10 Hydroxyproline Standards for hydrogels (per 5 plates)
1. Create a 50 µg/ml hydroxyproline solution from the 1 mg/mL stock solution:
• Take 50 µl of hydroxyproline stock solution (1mg/ml)
• Add 950 µl PB
2. Vortex and briefly spin hydroxyproline solution (50 µg/ml) in benchtop cen-
trifuge.
3. Prepare standards in 1.5 ml microtubes as detailed in table below
4. Vortex standards and spin briefly in benchtop centrifuge
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Table C.1.
Dilution of standard HYP working solution with PB as table below:
Standard ID Vol 50g/ml HYP (µl) Vol PB to 1000l
Add 60 µl to each well
(ng/well)
1 0 1000 0
2 5 995 15
3 20 980 60
4 40 960 120
5 70 930 210
6 100 900 300
7 125 875 325
8 150 850 450
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C.11 Assay Procedure
1. Add 60 µl (in triplicate) of standards(Fluka) and samples to wells of a clear
round-bottomed 96 well plate.
2. Using the multichannel pipet, add to each well:
• 20 µl of Assay Buffer
• 40 µl of Chloramine-T Reagent
3. Cover plate with tinfoil and incubate for 20min at room temperature to allow
hydroxyproline oxidation to complete
4. Add 80 µl of DMBA reagent using the multichannel pipet. Solution will become
cloudy. It is essential to mix the contents using the pipet until the solution
becomes clear.
5. Cover with SealPlate and incubate in an oven at 600C for 20 mins.
6. Cover plate with tinfoil and place on baking tray and allow to cool for 25 mins.
7. Remove sealplate carefully after cooling.
8. Read in plate reader at 570 nm. Hydroxyproline levels in samples can be esti-
mated from the standard curve.
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D. DMMB ASSAY FOR CARTILAGE TISSUE
D.1 Materials
• Chondroitin Sulfate (Sigma, C4384)
• 1,9-Dimethyl-Methylene Blue (Sigma, 341088-1G)
• Formic Acid (EMD, FX0440)
• 1 M NaOH
• Papain Buffer (PB)
• Clear, round bottomed 96-well plate
D.2 Protocol
1. Prepare standards:
• Dissolve 1mg chondroitin sulfate into 1 ml PB (1 mg/ml, stock solution)
• Dilute stock solution 1:10 in PB (100 µg/ml, standard working solution
Table D.1.
Dilution of standard DMMB working solution with PB as table below:
µg GAGs µL working solution µL PB
0 0 100
1.25 12.5 87.5
2.5 25 75
5 75 25
10 100 100
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2. Prepare DMMB Stock Solution (wrap in foil and store at RT):
• 16 mg DMMB
• 2 ml Format Buffer (15.4 µl Formic Acid, 29.4 µl 1M NaOH, 5 ml DI H20,
pH=3.5)
• 5 ml EtOH
• 1.91 g GuHCl
• 93 ml DI H20
3. Prepare DMMB Working Solution (make fresh):
• Dilute Stock Solution in DI H20 1:4.75
4. Prepare Dissociation Reagent:
• 90 ml PB
• 10 ml 1-propanol
• 38.2 g GuHCl
5. For gels, place a total of 100 µl (sample+PB) into new 1.5 ml micro-centrifuge
tubes. For media samples, place a total of 400 µl (sample+DMEM) into new
1.5 ml micro-centrifuge tubes. Add 1 ml of DMMB Working Solution to each
sample, and rotate/mix well for 30 minutes.
6. Centrifuge at 15,000xg for 10 minutes. All dye bound to sGAG will pellet at the
bottom of the tube.
7. Remove solution from the above the and leave pallet at the bottom without
disturbance.
8. Add 1 ml Dissociation Reagent to each tube, and vortex/mix until pellet is fully
dissolved.
9. Pipet 200 µl of standards in triplicate into a 96 well plate
10. Pipet 200 µl of samples in triplicate into plate.
11. Analyze using DMMB Assay protocol on plate reader.
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12. Calculate µg of sGAG by fitting data to linear standard curve.
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E. PICO GREEN ASSAY
E.1 Solutions
Add 2 ml 20x TE to 38 ml nuclease free H2O. Make up in 50 ml centrifuge tube.
Save excess for future use.
DNA Standards
1. Prepare standard curve with DNA provided in PicoGreen kit.
2. Store at 40C for future use.
PicoGreen Working Solution
1. Dilute PicoGreen stock solution 1:200 in TE buffer.
2. only what you need. Protect from light.
Table E.1.
Dilution of standard DNA working solution with TE as table below:
Final Conc.
in well (ng)
Volume DNA (µl) Volume TE (ml)
A 0 0 1.2
B 1 120 of C 1.08
C 10 120 of D 1.08
D 100 120 of E 1.08
E 1000 26 µl(100µg/ml) 1.17
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E.2 Protocol
1. Pipet 100 µl standards in triplicate into black microplate.
2. Diluted the stock solution 2:1000 µl with 1X TE Buffer.
3. Add 3 µl and 20 µl of diluted solution from the full thickness and the superficial
zone. For making 100 µl of sample 97 µl and 80 µl of 1X TE buffer have added
in the black plate reader. Note: Those ratios can change based on amount of
DNA present in sample, but the total MUST be 100 µl to match standard.
4. Add 100 µl PicoGreen working solution to each well using the multipipette.
5. Protect from light. Incubate 5 minutes at room temperature.
6. Read plate using the fluorescent PicoGreen protocol on plate reader.
7. Calculate ng of DNA by fitting data to linear standard curve.
